Although the therapeutic potential of HO-1 and its mechanism of action are still largely unknown in patients, upregulation of HO-1 gene expression is a potential future clinical implication to improve metabolic balance and attenuate hepatic fibrosis. This evidence concerns the gene HMOX1 and Hepatic fibrosis.